Coronavirus Resource Center

• World Health Organization (WHO)
• CDC Centers for Disease Control and Prevention
• State Employment Security Department
• WA State Department of Health
• Seattle & King County Public Health

• June 12: Safe Start King County – Now in modified Phase 1
• March 31: Essential Business List Update
• March 24: Critical Exemptions for Life Science Organizations Included in Gov. Inslee’s “Stay Home, Stay Safe” Policy
• March 23: Gov. Inslee announces “Stay Home, Stay Healthy” order

• SBA and Treasury Announce New and Revised Guidance Regarding the Paycheck Protection Program
• Coronavirus Aid, Relief and Economic Security (CARES) Act: The Federal Coronavirus Aid, Relief, and Economic Security (CARES) Act that was passed this week by Congress contains unprecedented funding and resources to help businesses maintain operations and keep employees on the payroll during the COVID-19 outbreak.
• BIO Summary of CARES Act: is an overview of key provisions in the bill that relate to life science companies
• CARES Act Small Business Funding  is a summary of financial resources available to help companies (and non-profit organizations) maintain business operations (loans, grants, payroll assistance, etc.).
• SBA Small Business Assistance & Resources provides information on how to access federal small business assistance programs.
• WA Employment Security Guidance for Washington State employers impacted by COVID-19.  
• Fisher Phillips (labor and employment law firm) COVID-19 Resources

• The Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services has been provided with $2B through the CARES Act to invest in research and development of vaccines, therapeutics, and diagnostics to combat COVID-19. BARDA is pursuing the following: vaccines, diagnostics, potential therapeutics, ventilators, immunomodulators or therapeutics targeting lung repair, pre and post-exposure prophylaxis, and respiratory protective devices.
• BARDA DRIVe Accelerator: BARDAs Division of Research, Innovation, and Ventures (DRIVe) provide technical and financial resources to entrepreneurs whose ideas have the potential to transform emergency preparedness, detection, and response. Life Science Washington Institute has been selected as one of 13 sites in the DRIVe Accelerator Network to help identify relevant researchers and companies and connect them with the DRIVe team. 
• InfoEd Global, a provider of software that supports the Electronic Research Administration, has compiled a library of COVID-19 funding opportunities and resources.
• National Science Foundation Request for SBIR/STTR Phase I Proposals Addressing COVID-19: The Division of Innovation and Industrial Partnerships (IIP) of the Engineering Directorate invites US-based small businesses to submit Phase I proposals focused on the development and deployment of new technologies, products, processes, and services with the ability to respond to the COVID-19 crisis. 
• HHS EZ-BAA for Diagnostics: HHS announced an Easy Broad Agency Announcement (EZ-BAA) for development of COVID-19 diagnostics. Solicitation BAA-20-100-SOL-0002
• FDA Template for Diagnostics EUA: FDA has developed a COVID-19 Emergency Use Authorization (EUA) template for diagnostic developers, available upon request. Sponsors interested in potential Emergency Use Authorization (EUA) for tests to detect COVID-19 may contact CDRH-EUA-Templates@fda.hhs.gov. COVID-19 molecular assays for mature, FDA-cleared, widely placed devices are of great interest to the Agency.
• Gates-Wellcome Trust-Mastercard COVID-19 Therapeutics Accelerator: In March 2020, The Bill & Melinda Gates Foundation, the Wellcome Trust, and Mastercard announced $125 million in seed funding to accelerate the development of therapeutics for COVID-19. The accelerator aims to identify, assess,develop, and scale up treatments.

• Fisher Phillips (labor and employment law firm) COVID-19 Resources
• WA Employment Security Guidance for Washington State employers impacted by COVID-19

• Give Blood: Blood Supply Hits Emergency Level Due to Coronavirus Concerns. The increase in COVID-19 cases in Seattle and surrounding counties has led to a shortage in blood products due to a decline in donations. Make an appointment to donate blood.
• Medical Volunteers Needed: King County Department of Health needs medical volunteers. Medical experts in our community can make a difference now to save lives. Simply email hmac.03@kingcounty.gov with name, phone, medical background, and availability to be assigned accordingly.
• Contribute: The King County Medical Society (KCMS) in partnership with the Expedia Group is responding to the growing needs of PPE. Partnering with local garment manufacturers, and professional tailors and sewers, to quickly and effectively produce needed equipment for our frontline health care workers. Donate today just for $25 for a single PPE kit (mask, gown, and cap). If employers have a matching gift program, please contact Nancy L. Belcher at nbelcher@kcmsociety.org
• Donations to UW: Gifts are urgently needed to ramp up COVID-19 testing, provide care for the most vulnerable, coordinate the state’s emergency response, support research, and provide lifesaving equipment and resources to ensure the health and well-being of UW patients and clinical teams.

• UW Medicine Virology: The University of Washington is working to provide clear information by curating a weekly snap shot of current data and information regarding the University of Washington and UW Medicine’s response to COVID-19. 
• AGC Biologics: Novavax selects AGC Biologics to manufacture Matrix-M™ Adjuvant for COVID-19 Vaccine
• Bill & Melinda Gates Foundation: Pledging an additional $1.6 billion to the Gavi vaccine alliance for the next five years, plus an additional $100 million specifically for COVID-19 vaccines, preparing to fight the pandemic in low-income countries.